Welcome to our dedicated page for Cronos Group Common Share news (Ticker: $CRON), a resource for investors and traders seeking the latest updates and insights on Cronos Group Common Share stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cronos Group Common Share's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cronos Group Common Share's position in the market.
News
Rhea-AI Summary
Cronos Group Inc. (CRON) announced the sale and leaseback of its Peace Naturals Campus to Future Farmco Canada Inc. for C$23 million cash, aiming to reduce costs and improve the gross margin profile of the business. The transaction is subject to certain conditions and is expected to close within 30 calendar days after all conditions are satisfied or waived.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.88%
Tags
-
Rhea-AI Summary
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announces its 2023 Q3 business results, with net revenue increasing by 22% year-over-year to $24.8 million. Spinach® achieved top-10 retail sales in Canada in Q3 2023 across various categories. The company also launched the Peace Naturals® brand in Germany and the award-winning Lord Jones® brand in Canada.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.82%
Tags
-
Rhea-AI Summary
Cronos Group Inc. has launched its Lord Jones® cannabis brand in the Canadian adult-use market. The brand will focus on THC-focused product innovations and deliver premium quality cannabis products. The first product to launch is the Lord Jones® Hash Fusions pre-rolls, which are crafted with an optimized ratio of high-potency flower and ice water hash. The pre-rolls offer a smooth smoke and bold cannabis flavors. Lord Jones® Hash Fusions will be available in select provinces this month and expanding to other provinces in early 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.64%
Tags
Rhea-AI Summary
Cronos Group Inc. has announced the launch of two new THCV-infused products, including a vape and gummy under the Spinach FEELZ™ brand. The Full Tilt THCV lineup aims to provide adult consumers with a unique cannabis experience. The vape contains 700mg of THC and 100mg of THCV per 1g cartridge, while the gummies offer 10mg of THC and 20mg of THCV per pack. The THCV vape is currently available in Alberta, British Columbia, and Ontario, and the THCV edibles are available in Ontario and British Columbia, with availability in Alberta expected by November 30. THCV-infused pre-rolls are planned for launch in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.91%
Tags
-
Rhea-AI Summary
Cronos Group Inc. will hold its 2023 Q3 earnings conference call on November 8. Senior management will discuss financial results and take questions from the investment community.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.81%
Tags
-
Rhea-AI Summary
Cronos Group's Spinach® brand wins 'Best Pre-Roll' at the Grow Up Awards for its Spinach® Fully Charged Atomic GMO infused pre-rolls.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
Cronos Group ships first order of bulk cannabis to Germany, aiming to establish PEACE NATURALS® as a top medical brand. Regulatory changes and potential legalization of adult-use cannabis in Germany expected to drive significant market growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.86%
Tags
-
Rhea-AI Summary
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announces its 2023 second quarter business results, highlighting an industry-leading balance sheet with $841 million in cash and short-term investments, an increased 2023 operating expense savings target to $20 to $25 million, and additional initiatives to streamline supply chain and improve cash flow. Spinach® was top-10 in retail sales in every category it participates in - flower, edible, vape and pre-roll, in Q2 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.37%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.6%
Tags
Rhea-AI Summary
Cronos Group Inc. confirms receiving unsolicited indications of interest from third parties for potential transactions. The company is reviewing these indications but no assurance of agreement or transaction. No further announcements unless required by law.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.91%
Tags
Cronos Group Inc. Common Share
Nasdaq:CRON
CRON Rankings
CRON Stock Data
1.01B
203.49M
46.57%
13.1%
1.46%
Medicinal and Botanical Manufacturing
Manufacturing
United States of America
TORONTO
About CRON
cronos group is a globally diversified and vertically integrated cannabis company with a presence across four continents. the company operates two wholly-owned canadian licensed producers regulated under health canada’s access to cannabis for medical purposes regulations: peace naturals project inc. (ontario), which was the first non-incumbent medical cannabis license granted by health canada, and original bc ltd. (british columbia), which is based in the okanagan valley. the company has multiple international production and distribution platforms: cronos israel and cronos australia. through an exclusive distribution agreement, cronos also has access to over 12,000 pharmacies in germany as the company focuses on building an international iconic brand portfolio and developing disruptive intellectual property.